[go: up one dir, main page]

KR930004460A - 에이(a) 87689 화합물 - Google Patents

에이(a) 87689 화합물 Download PDF

Info

Publication number
KR930004460A
KR930004460A KR1019920013799A KR920013799A KR930004460A KR 930004460 A KR930004460 A KR 930004460A KR 1019920013799 A KR1019920013799 A KR 1019920013799A KR 920013799 A KR920013799 A KR 920013799A KR 930004460 A KR930004460 A KR 930004460A
Authority
KR
South Korea
Prior art keywords
compound
pharmaceutically acceptable
salt
quautromicin
penta
Prior art date
Application number
KR1019920013799A
Other languages
English (en)
Inventor
랜돌프 베리 데니스
홀린스 단지그 앤
데보노 마뉴엘
엘. 해밀 로버트
마이클 몰로이. 시니어 로버트
체-홍 야오 레이몬드
매튜 콜라시노 죠셉
치오우-청 탕 죠셉
Original Assignee
리로이 휘테커
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리로이 휘테커, 일라이 릴리 앤드 캄파니 filed Critical 리로이 휘테커
Publication of KR930004460A publication Critical patent/KR930004460A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

내용 없음.

Description

에이(A) 87689 화합물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 A87689칼슘염을 나타낸다.
제2도는 A87689 유리산을 나타낸다.
제3도는 A87689 테트라아세테이트 칼슘염을 나타낸다.

Claims (7)

  1. A87689, 또는 A87689의 C1-6-알킬 에테르 또는 C1-6-알카노일 에스테르 유도체 또는 그의 약학적으로 허용되는 염.
  2. A87689.
  3. A87689의 칼슘염.
  4. A87689의 유리산.
  5. A87689의 펜타-나트륨염.
  6. 활성 성분으로, 제1,2,3,4 또는 5항에 청구된 바와 같은 A87689화합물을 그에 대한 하나 이상이 약학적으로 허용되는 담체, 부형제 또는 희석제와 함께 포함하는 약학 제제.
  7. PLA2를 억제하는데 사용하기 위한 콰트로마이신(quautromicin)유도체.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920013799A 1991-08-01 1992-07-31 에이(a) 87689 화합물 KR930004460A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US738,969 1976-11-04
US73896991A 1991-08-01 1991-08-01
US88972292A 1992-05-28 1992-05-28
US07/889,722 1992-05-28

Publications (1)

Publication Number Publication Date
KR930004460A true KR930004460A (ko) 1993-03-22

Family

ID=27113454

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920013799A KR930004460A (ko) 1991-08-01 1992-07-31 에이(a) 87689 화합물

Country Status (14)

Country Link
EP (1) EP0526258A2 (ko)
JP (1) JPH05213999A (ko)
KR (1) KR930004460A (ko)
CN (1) CN1073979A (ko)
AU (1) AU2072092A (ko)
BR (1) BR9202993A (ko)
CA (1) CA2075163A1 (ko)
CZ (1) CZ233892A3 (ko)
FI (1) FI923487L (ko)
HU (1) HUT65398A (ko)
IL (1) IL102679A0 (ko)
MX (1) MX9204419A (ko)
NO (1) NO923029L (ko)
YU (1) YU75192A (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012055814A1 (en) * 2010-10-25 2012-05-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) Compound inducing lbpa accumulation for inhibiting cell-to-cell transmission of hiv

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0407939A1 (en) * 1989-07-10 1991-01-16 Bristol-Myers Squibb Company Antiviral antibiotic BU-3889V

Also Published As

Publication number Publication date
FI923487A0 (fi) 1992-07-31
IL102679A0 (en) 1993-01-14
HUT65398A (en) 1994-06-28
YU75192A (sh) 1995-10-03
HU9202478D0 (en) 1992-10-28
CZ233892A3 (en) 1993-02-17
CN1073979A (zh) 1993-07-07
EP0526258A3 (ko) 1994-04-27
FI923487L (fi) 1993-02-02
BR9202993A (pt) 1993-03-30
NO923029D0 (no) 1992-07-31
CA2075163A1 (en) 1993-02-02
JPH05213999A (ja) 1993-08-24
MX9204419A (es) 1993-02-01
AU2072092A (en) 1993-02-04
EP0526258A2 (en) 1993-02-03
NO923029L (no) 1993-02-02

Similar Documents

Publication Publication Date Title
KR870005637A (ko) 약물 데포
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
ES2083668T3 (es) Combinaciones antiviricas que contienen analogos de nucleosidos.
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX9402922A (es) Composiciones farmaceuticamente aceptables mejoradas.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
KR910000703A (ko) 테트라졸 자극성 아미노산 수용체의 길항물질
SE8300736D0 (sv) Novel pharmacologically active compounds
MX9200180A (es) DERIVADOS DE LA 5H-PIRROL (3,4-b) PIRAZINA OPTICAMENTE ACTIVOS, PROCEDIMIENTO PARA SU PREPARACION Y COMPOSICION FARMACEUTICA QUE LOS CONTIENE.
NO863636L (no) Fremgangsmaate for fremstilling av transdermalt resorberbare preparater av arylpropionsyrederivater.
KR920018024A (ko) 피페리딘 유도체
KR910018381A (ko) 개선된 에르골린-8-카복스아미드
NO940523L (no) Nye pyrazin-derivater
KR890015742A (ko) 이병치료용 국소 제제
KR910021375A (ko) 4-(디-n-프로필)아미노-6-아미노카보닐-1,3,4,5-테트라하이드로벤즈[cd]인돌의 결정형 염
ES2060173T3 (es) Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
NO923721L (no) 4-desoksy-4-epipodophyllotoxin-derivat eller farmasoeytiskakseptabelt salt derav
FR2674754B1 (fr) Composition medicamenteuse micronisee.
PH27446A (en) Compound with gastric acid inhibitory effect
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
KR890011588A (ko) 간 섬유증 억제제
KR930004460A (ko) 에이(a) 87689 화합물
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19920731

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid